Aspects of dioxin toxicity are mediated by interleukin 1-like cytokines

Molecular Pharmacology

Volumn 67, Issue 5, 2005, Pages 1393-1398

  Pande, Kalyan ^a   Moran, Susan M ^a   Bradfield, Christopher A ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALANINE AMINOTRANSFERASE; CYTOKINE; DIOXIN; HYDROCARBON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEGENERATION; HEPATITIS; HEPATOMEGALY; INVOLUTION; LIVER CELL DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; DIOXINS; INTERLEUKIN-1; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 17844380221     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.010983     Document Type: Article

References (26)

1. Blazka ME, Elwell MR, Holladay SD, Wilson RE, and Luster MI (1996) Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 24:181-189.
2. Bradham CA, Plumpe J, Manns MP, Brenner DA, and Trautwein C (1998) Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol 275:G387-G392.
3. Carver LA, LaPres JJ, Jain S, Dunham EE, and Bradfield CA (1998) Characterization of the Ah Receptor-associated protein, ARA9. J Biol Chem 273:33580-36159.
4. Charles GD and Shiverick KT (1997) 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases mRNA levels for interleukin-1beta, urokinase plasminogen activator and tumor necrosis factor-alpha in human uterine endometrial adenocarcinoma RL95-2 cells. Biochem Biophys Res Commun 238:338-342.
5. Diehl AM (2000) Cytokine regulation of liver injury and repair. Immunological Rev 174:160-171.
6. Erickson SL, de Sauvage FJ, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC, Schreiber RD, Goeddel DV, and Moore MW (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature (Lond) 372:560-563.
7. Fan F, Yan B, Wood G, Viluksela M, and Rozman KK (1997) Cytokines (IL-1beta and TNFalpha) in relation to biochemical and immunological effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats. Toxicology 116:9-16.
8. Fisher MT, Nagarkatti M, and Nagarkatti PS (2004) Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity. Toxicol Sci 78:116-124.
9. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, Livingston DJ, Peschon JJ, and Morrissey PJ (1997) Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J Immunol 159:3384-3371.
10. Gu Y-Z, Hogenesch JB, and Bradfield CA (2000) The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:519-561.
11. Maher JJ and Gores GJ (1998) Apoptosis: silent killer or neutron bomb? Hepatology 28:865-867.
12. Martinez-Pomares L, Platt N, McKnight AJ, da Silva RP, and Gordon S (1996) Macrophage membrane molecules: markers of tissue differentiation and heterogeneity. Immunobiology 195:407-416.
13. McClain CJ, Barve S, Barve S, Deaciuc I, and Hill DB (1998) Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 22:248S-252S.
14. Moos AB, Baecher-Steppan L, and Kerkvliet NI (1994) Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8- tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF. Toxicol Appl Pharmacol 127:331-335.
15. Moshage H (1997) Cytokines and the hepatic acute phase response. J Pathol 181:257-266.
16. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, and Mak TW (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467.
17. Pohjanvirta R and Tuomisto J (1994) Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms and animal models, Pharmacol Rev 46:483-549.
18. Poland A and Glover E (1980) 2,3,7,8,-Tetrachlorodibenzo-p-dioxin: segregation of toxicity with the Ah locus. Mol Pharmacol 17:86-94.
19. Poland A, Glover E, and Taylor BA (1987) The murine Ah locus: a new allele and mapping to chromosome 12. Mol Pharmacol 32:471-478.
20. Ramadori G and Armbrust T (2001) Cytokines in the liver. Eur J Gastroenterol Hepatol 13:777-784.
21. Schmidt JV and Bradfield CA (1996) Ah receptor signaling pathways. Annu Rev Cell Dev Biol 12:55-89.
22. Schulte-Hermann R (1974) Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol 3:97-158.
23. Schumann J and Tiegs G (1999) Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins. Toxicology 138:103-126.
24. Taylor MJ, Lucier GW, Mahler JF, Thompson M, Lockhart AC, and Clark GC (1992) Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone. Toxicol Appl Pharmacol 117:126-132.
25. Turner JN and Collins DN (1983) Liver morphology in guinea pigs administered either pyrolysis products of a polychlorinated biphenyl transformer fluid or 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 67:417-429.
26. Yin M, Wheeler MD, Kono H, Bradford BU, Gallucci RM, Luster MI, and Thurman RG (1999) Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology 117:942-952.